Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124778312 | 12477831 | 2 | F | 20160408 | 20160808 | 20160617 | 20160811 | EXP | US-ALLERGAN-1653860US | ALLERGAN | 56.00 | YR | F | Y | 129.25000 | KG | 20160811 | OT | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124778312 | 12477831 | 1 | PS | VIBERZI | ELUXADOLINE | 1 | Oral | 75 MG, UNK | Y | 206940 | 75 | MG | TABLET | ||||||
| 124778312 | 12477831 | 2 | SS | VICTOZA | LIRAGLUTIDE | 1 | Subcutaneous | 0.6 MG, QD | 2.4000001 | MG | Y | U | 0 | .6 | MG | QD | |||
| 124778312 | 12477831 | 3 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | 40 MG, UNK | U | 0 | 40 | MG | QD | |||||||
| 124778312 | 12477831 | 4 | C | VITAMIN D2 | ERGOCALCIFEROL | 1 | Oral | 50000 UNITS, TUESDAY AND THURSDAY | U | 0 | |||||||||
| 124778312 | 12477831 | 5 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 100/50 | U | 0 | |||||||||
| 124778312 | 12477831 | 6 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 40 MG, QD | U | 0 | 40 | MG | QD | ||||||
| 124778312 | 12477831 | 7 | C | REGLAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | 5 MG, EVERY 6 HR, PRN | U | 0 | 5 | MG | ||||||||
| 124778312 | 12477831 | 8 | C | LOPRESSOR | METOPROLOL TARTRATE | 1 | Oral | 100 MG, UNK | U | 0 | 100 | MG | BID | ||||||
| 124778312 | 12477831 | 9 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | 20 MG, QD | U | 0 | 20 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124778312 | 12477831 | 1 | Irritable bowel syndrome |
| 124778312 | 12477831 | 2 | Product used for unknown indication |
| 124778312 | 12477831 | 3 | Product used for unknown indication |
| 124778312 | 12477831 | 4 | Product used for unknown indication |
| 124778312 | 12477831 | 5 | Product used for unknown indication |
| 124778312 | 12477831 | 6 | Product used for unknown indication |
| 124778312 | 12477831 | 7 | Product used for unknown indication |
| 124778312 | 12477831 | 8 | Product used for unknown indication |
| 124778312 | 12477831 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124778312 | 12477831 | HO |
| 124778312 | 12477831 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124778312 | 12477831 | Abdominal hernia | |
| 124778312 | 12477831 | Acute kidney injury | |
| 124778312 | 12477831 | Acute respiratory failure | |
| 124778312 | 12477831 | Atelectasis | |
| 124778312 | 12477831 | Feeling of body temperature change | |
| 124778312 | 12477831 | Headache | |
| 124778312 | 12477831 | Hypotension | |
| 124778312 | 12477831 | Ileus | |
| 124778312 | 12477831 | Liver function test abnormal | |
| 124778312 | 12477831 | Pancreatitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124778312 | 12477831 | 1 | 20160408 | 20160408 | 0 | |
| 124778312 | 12477831 | 2 | 20160405 | 20160409 | 0 |